-
As Agilent's Alissa interpret will be discontinued, we've designed a smooth migration plan to move easily to SeqOne Platform.
Learn more & start your transition >
Introducing the most advanced platform for clinical genomic analysis…
Don’t miss
a mutation
State-of-the-art bioinformatics tools that identify complex genomic events overlooked by standard bioinformatic pipelines
Increase your team’s productivity
End-to-end germline and somatic analysis solution that manages the entire process from raw data to the clinical report
Meet quality and compliance goals
Tools to help you meet your quality control and regulatory compliance goals with support for your team in their efforts
Keep your data safe and accessible
Scalable and secure architecture that simplifies data management and meets your security and confidentiality requirements
Solutions for each type of medical use
Solutions for Labs
Empower your labs to deliver a range of state-of-the-art tests with ultra-high accuracy and optimum efficiency.
Solutions for Biopharmas
Optimize your trial and market access project with fast, accurate genomic analysis and access to patient cohorts.
Using data and machine learning to build a
more accurate picture of each patient
We are passionate about creating bioinformatic solutions that target hard-to-detect variants such as MNVs, Alu elements and mid-sized deletions. These challenging variants are important because research continues to discover ways in which they impact patient health. Our custom bioinformatic modules complement the industry-standard bioinformatic tools, making it possible to detect important variants that would otherwise be undetected.
SeqOne regularly publishes and shares many of its research results via the open source community.
Satisfied customers
About SeqOne
The vision uniting the SeqOne team is a desire to improve patient outcomes with improved genomic analysis. We use significant resources on research and development to ensure that our platform offers the most effective, easy-to-use solution.
This ambitious program is driven by a team of experts covering all aspects of medical genomics; from clinicians, bioinformaticians, biologists and information technology specialists to experts in algorithmics, artificial intelligence, security and big data.
SeqOne News
-
News Press release26 October 2023
SeqOne Genomics appoints Martin Dubuc, Senior Pharmaceutical and Digital Health Executive to its Board of Directors
M. Dubuc will strengthen the Board’s capabilities in the fields of personalized medicine and companion diagnostics Montpellier, France - Thursday, 26th of October, 2024 – [...]
-
Events News
22 September 2023
Genomic data interpretation workshop & lunch seminar in Graz
We will be hosting a workshop & lunch seminar about genomic data interpretation. DATE: November 8th 2023 starting at 10:00, with lunch at 12:00 LOCATION: [...]
-
Events News
11 May 2023
SeqOne at ESHG 2023: A.I. for Diagnostics
We will be hosting a corporate satellite on Monday, June 12, 2023 – 14.00 – 15.30 BST : "Harnessing AI to improve diagnostic yield with [...]
-
News Press release
22 February 2023
SeqOne’s new clinically validated HRD test reduces the number of inconclusive results to improve the prescription of targeted treatments for ovarian cancer patients
The Homologous Recombination Deficiency (HRD) biomarker identifies ovarian cancer patients likely to respond to PARP inhibitors. SeqOne’s test simplifies the deployment of this test while [...]
